glp-1 for obesity kenner GLP-1s are not “making people in larger bodies feel like thin people.” That framing oversimplifies human biology and can worsen weight stigma by implying certain bodies deserve less nourishment than others. As GLP-1-based therapies for diabetes, obesity

When you look at the exhaustive clinical trials conducted for FDA approval, weight loss doesn't appear as a common or even uncommon side effect

NovoCare offers the pill at $149 per month for the starter dose through at least August 2026, making it the cheapest FDA-approved GLP-1 option for cash-pay patients

His fitness and enjoyment of life can deteriorate

As brand name manufacturing capacity has increased to meet patient demand, the FDA has removed some of the GLP-1 drugs from the drug shortage list, leading to lawsuits filed by the compounding pharmacies against FDA

By attaching itself to its receptors and activating adenylate cyclase (AC), which raises cAMP levels in the myocardium, glucagon also increases cardiac output